Overview
- 5 FDA inspections are on record.
- 5 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-10-30.
At a glance
Inspections
5
Form 483s
5
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 20 Oct 2025 – 30 Oct 2025 | Human Drugs | 483 | View 483 → |
| 2 May 2023 – 17 May 2023 | Human Drugs | 483 | View 483 → |
| 28 Oct 2019 – 7 Nov 2019 | Human Drugs | 483 | On file |
| 25 Sep 2017 – 29 Sep 2017 | Human Drugs | 483 | View 483 → |
| 17 Mar 2014 – 2 Apr 2014 | Human Drugs | WL | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
17 May 2023
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Margaret M Annes, Lisa R Hilliard, Megan T Ziegler
Investigators
FDA investigators tied to this site in the record.
Claire M Minden2 insp.
Demario L Walls1 insp.
Margaret M Annes1 insp.
Lisa R Hilliard1 insp.
Megan T Ziegler1 insp.
Nimmy Mathews1 insp.
Linda F Murphy1 insp.
Zachery L Miller1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 4x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.28(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(iii) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(vi) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.160(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.42(c)(10)(v) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
| FDCA 503B(a)(10) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind SCA Pharmaceuticals, Inc.'s 5 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat